No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
No analyst estimates.
4 funds hold a position.
No tracked top-trader positions in NRT as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Sep 4, 2026
Period ending
Jul 31, 2026
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 4, 2026 | Unavailable | - | $2.7M No estimateSEC filing | Unavailable |
| Apr 30, 2026 | Jun 5, 2026 | Unavailable | - | $2.4M No estimateSEC filing | Unavailable |
| Jan 31, 2026 | Mar 2, 2026 | Unavailable | - | $2.2M No estimateSEC filing | Unavailable |
| Oct 31, 2025 | Dec 31, 2025 | Unavailable | - | Unavailable | Unavailable |
| Jul 31, 2025 | Aug 29, 2025 | Unavailable | - | $2.6M No estimateSEC filing | Unavailable |
| Apr 30, 2025 | May 30, 2025 | Unavailable | - | $2.5M No estimateSEC filing | Unavailable |
| Jan 31, 2025 | Feb 28, 2025 | Unavailable | - | $519.4K No estimateSEC filing | Unavailable |
| Oct 31, 2024 | Dec 31, 2024 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
Fairly priced and profitable.
Valuation
Quality
Growth
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace